ImmunoGen
IMGN

股本结构

单位：万股
公告日期 2024-01-02 2024-01-02 2023-11-02 2023-11-02 2023-07-31 2023-07-31
证券总股本 27935.40 26766.24 26626.43 26584.20 24894.34 24871.20
普通股本 27935.40 26766.24 26626.43 26584.20 24894.34 24871.20
优先股 未披露 2.19 未披露 2.20 未披露 2.20
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2023-12-29 2023-11-27 2023-10-25 2023-09-30 2023-07-25 2023-06-30
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2024-01-02 27935.40 未披露 定期报告 2023-12-29
2024-01-02 26766.24 2.19 定期报告 2023-11-27
2023-11-02 26626.43 未披露 定期报告 2023-10-25
2023-11-02 26584.20 2.20
更多>>
From June 30, 2023 to September 30, 2023 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Directors’ deferred share unit and common stock compensation Issuance of common stock pursuant to pre-funded warrant exchange
2023-09-30
2023-07-31 24894.34 未披露 定期报告 2023-07-25
2023-07-31 24871.20 2.20
更多>>
From March 31, 2023 to June 30, 2023 Issuance of common stock pursuant to pre-funded warrant exchange Issuance of Series A Preferred Stock in exchange for common stock Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Issuance of common stock, net of issuance costs Directors’ deferred share unit and common stock compensation
2023-06-30
2023-05-05 25597.04 未披露
更多>>
Common stock offered 26,000,000 shares by the company Pursuant to the terms of the Underwriting Agreement, the Company granted the Underwriters an option, exercisable for 30 days following the date of the Underwriting Agreement, to purchase up to an additional 3,900,000 shares of Common Stock at the same price, which the Underwriters exercised on May 5, 2023. The Offering is scheduled to close on May 9, 2023, subject to the satisfaction of customary closing conditions.
2023-05-09
2023-04-26 22607.04 未披露 定期报告 2023-04-10
2023-04-28 22607.00 未披露
更多>>
From December 31, 2022 to March 31, 2023 Directors’ deferred share unit and common stock compensation Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan
2023-03-31
2023-03-01 22604.61 未披露 定期报告 2023-02-21
2023-03-01 22604.60 未披露
更多>>
From December 31, 2021 to December 31, 2022 Issuance of common stock, net of issuance costs Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Restricted stock units vested
2022-12-31
2022-11-04 22075.09 未披露 定期报告 2022-10-31
2022-11-04 22075.10 未披露
更多>>
From June 30, 2022 to September 30, 2022 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan
2022-09-30
2022-08-01 22071.31 未披露 定期报告 2022-07-25
2022-08-01 22064.40 未披露
更多>>
From March 31, 2022 to June 30, 2022 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan
2022-06-30
2022-04-26 22053.60 未披露 定期报告 2022-04-08
2022-05-06 22053.60 未披露
更多>>
From December 31, 2021 to March 31, 2022 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Restricted stock units vested
2022-03-31
2022-02-28 22053.09 未披露 定期报告 2022-02-16
2022-02-28 22036.10 未披露
更多>>
From December 31, 2020 to December 31, 2021 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Issuance of common stock, net of issuance costs Conversion of convertible senior notes Restricted stock units vested Restricted stock award forfeitures
2021-12-31
2021-12-03 21992.97 未披露
更多>>
1.Common stock offered by company 11,636,364 shares.the Company granted the Underwriters an option, exercisable for 30 days following the date of the Underwriting Agreement, to purchase up to an additional 5,850,000 shares of Common Stock at the same price. 2.The number of shares of common stock to be outstanding after this offering is based on 202,443,297 shares of common stock outstanding as of September 30, 2021.
2021-12-06
2021-10-29 20261.95 未披露 定期报告 2021-10-26
2021-11-30 20244.33 未披露
更多>>
From June 30, 2021 to September 30, 2021 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Issuance of common stock, net of issuance costs Restricted stock award forfeitures
2021-09-30
2021-08-12 20240.49 未披露 定期报告 2021-08-09
2021-07-30 20162.53 未披露 定期报告 2021-07-27
2021-07-30 20025.50 未披露
更多>>
From March 31, 2021 to June 30, 2021 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Conversion of convertible senior notes
2021-06-30
2021-04-28 19994.22 未披露 定期报告 2021-04-12
2021-05-10 19994.10 未披露
更多>>
From December 31, 2020 To March 31, 2021 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Issuance of common stock, net of issuance costs Restricted stock units vested
2021-03-31
2021-03-01 19973.18 未披露 定期报告 2021-02-18
2021-03-01 19499.80 未披露
更多>>
From December 31, 2019 to December 31, 2020 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Issuance of common stock, net of issuance costs Restricted stock units vested Restricted stock award forfeitures
2020-12-31
2020-12-18 19470.97 未披露 定期报告 2020-12-17
2020-11-06 18752.77 未披露 定期报告 2020-10-30
2020-12-18 17458.45 未披露
更多>>
From June 30, 2020 to September 30, 2020 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan
2020-09-30
2020-08-05 17454.21 未披露 定期报告 2020-07-30
2020-09-25 17453.97 未披露
更多>>
From March 31, 2020 to June 30, 2020 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Restricted stock units vested
2020-06-30
2020-05-05 17440.59 未披露 定期报告 2020-04-30
2020-04-28 17439.87 未披露 定期报告 2020-04-13
2020-05-05 17426.10 未披露
更多>>
From December 31, 2019 to March 31, 2020 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Issuance of common stock, net of issuance costs Restricted stock units vested Restricted stock award forfeitures
2020-03-31
2020-03-11 17432.09 未披露 定期报告 2020-03-04
2020-03-11 15013.60 未披露
更多>>
from December 31, 2018 to December 31, 2019 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Restricted stock award - net of forfeitures
2019-12-31
2019-11-05 14969.53 未披露 定期报告 2019-10-31
2019-11-05 14968.80 未披露
更多>>
from June 30, 2019 to September 30, 2019 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Restricted stock award
2019-09-30
2019-08-07 14988.48 未披露 定期报告 2019-07-31
2019-08-07 14988.50 未披露
更多>>
from March 31, 2019 to June 30, 2019 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Restricted stock award
2019-06-30
2019-04-30 14953.09 未披露 定期报告 2019-04-23
2019-05-07 14942.50 未披露
更多>>
from December 31, 2018 to March 31, 2019 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan
2019-03-31
2019-03-01 14940.98 未披露 定期报告 2019-02-19
2019-03-01 14940.00 未披露
更多>>
from December 31, 2017 to December 31, 2018 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Issuance of common stock Directors' deferred share units converted
2018-12-31
2018-11-02 14909.08 未披露 定期报告 2018-10-29
2018-11-02 14904.90 未披露
更多>>
from December 31, 2017 to September 30, 2018 Stock options exercised Issuance of common stock Directors' deferred share units converted
2018-09-30
2018-08-03 14902.13 未披露 定期报告 2018-07-31
2018-08-03 14902.10 未披露 定期报告 2018-06-30
2018-04-30 13303.69 未披露 定期报告 2018-04-23
2018-05-09 13302.40 未披露 定期报告 2018-03-31
2018-03-07 13284.65 未披露 定期报告 2018-02-28
2018-03-07 13252.60 未披露
更多>>
from December 31, 2016 to December 31, 2017 Stock options exercised Issuance of common stock Restricted stock award - net of forfeitures Conversion of debt Directors' deferred share units converted
2017-12-31
2017-08-04 8959.78 未披露 定期报告 2017-08-01
2017-08-04 8959.70 未披露 定期报告 2017-06-30
2017-05-05 8934.84 未披露 定期报告 2017-04-30
2017-04-28 8934.84 未披露 定期报告 2017-04-17
2017-05-05 8934.80 未披露 定期报告 2017-03-31
2017-03-03 8735.46 未披露 定期报告 2017-02-28
2017-03-03 8735.46 未披露 定期报告 2017-02-16
2017-03-03 8730.10 未披露
更多>>
from June 30, 2016 to December 31, 2016 Restricted stock award - net of forfeitures
2016-12-31
2016-10-28 8730.13 未披露 定期报告 2016-10-14
2016-11-04 8731.40 未披露 定期报告 2016-09-30
2016-08-25 8732.64 未披露 定期报告 2016-08-18
2016-08-25 8720.90 未披露
更多>>
from June 30, 2015 to June 30, 2016 Stock options exercised Restricted stock award
2016-06-30
2016-05-04 8707.70 未披露 定期报告 2016-04-28
2016-05-04 8707.70 未披露 定期报告 2016-03-31
2016-02-04 8706.09 未披露 定期报告 2016-01-29
2016-02-04 8704.00 未披露 定期报告 2015-12-31
2015-10-30 8698.46 未披露 定期报告 2015-10-27
2015-10-30 8698.10 未披露 定期报告 2015-09-30
2015-09-30 8697.57 未披露 定期报告 2015-09-15
2015-08-27 8696.15 未披露 定期报告 2015-08-27
2015-08-27 8696.15 未披露 定期报告 2015-08-20
2015-08-27 8657.90 未披露
更多>>
from June 30, 2014 to June 30, 2015 Stock options exercised Restricted stock award
2015-06-30
2015-05-08 8618.51 未披露 定期报告 2015-04-30
2015-05-08 8613.40 未披露 定期报告 2015-03-31
2015-02-05 8610.79 未披露 定期报告 2015-01-29
2015-02-05 8608.10 未披露 定期报告 2014-12-31
2014-10-30 8593.56 未披露 定期报告 2014-10-23
2014-10-30 8592.80 未披露 定期报告 2014-09-30
2014-09-30 8591.07 未披露 定期报告 2014-09-16
2014-08-28 8590.79 未披露 定期报告 2014-08-20
2014-08-28 8590.30 未披露
更多>>
from June 30, 2013 to June 30, 2014 Stock options exercised Directors' deferred share units converted
2014-06-30
2014-05-02 8581.37 未披露 定期报告 2014-04-23
2014-05-02 8580.70 未披露 定期报告 2014-03-31
2014-02-05 8567.27 未披露 定期报告 2014-01-27
2014-02-05 8562.90 未披露 定期报告 2013-12-31
2013-10-29 8539.53 未披露 定期报告 2013-10-21
2013-10-29 8527.00 未披露 定期报告 2013-09-30
2013-10-02 8517.24 未披露 定期报告 2013-09-17
2013-08-29 8510.91 未披露 定期报告 2013-08-20
2013-08-29 8472.50 未披露
更多>>
from June 30, 2012 to June 30, 2013 Stock options exercised Restricted stock award Issuance of common stock in a public offering, net of issuance costs
2013-06-30
2013-05-06 8453.38 未披露 定期报告 2013-04-29
2013-05-06 8443.70 未披露 定期报告 2013-03-31
2013-01-30 8422.20 未披露 定期报告 2013-01-22
2013-01-30 8418.80 未披露 定期报告 2012-12-31
2012-10-31 8412.05 未披露 定期报告 2012-10-24
2012-10-31 8411.70 未披露 定期报告 2012-09-30
2012-10-02 8411.20 未披露 定期报告 2012-09-18
2012-08-29 8410.46 未披露 定期报告 2012-08-21
2012-08-29 7775.90 未披露
更多>>
from June 30, 2011 to June 30, 2012 Stock options exercised Directors' deferred share units converted
2012-06-30
2012-05-10 7729.51 未披露 定期报告 2012-05-01
2012-05-10 7719.00 未披露 定期报告 2012-03-31
2012-01-31 7675.39 未披露 定期报告 2012-01-26
2012-01-31 7669.70 未披露 定期报告 2011-12-31
2011-10-31 7643.59 未披露 定期报告 2011-10-25
2011-10-31 7642.20 未披露 定期报告 2011-09-30
2011-08-29 7637.85 未披露 定期报告 2011-08-24
2011-08-29 7628.10 未披露
更多>>
from June 30, 2010 to June 30, 2011 Stock options exercised Issuance of common stock in a public offering, net of issuance costs
2011-06-30
2011-05-05 6826.02 未披露 定期报告 2011-04-27
2011-05-05 6812.10 未披露 定期报告 2011-03-31
2011-02-08 6803.72 未披露 定期报告 2011-02-02
2011-02-08 6802.50 未披露 定期报告 2010-12-31
2010-10-29 6796.37 未披露 定期报告 2010-10-26
2010-10-29 6795.20 未披露 定期报告 2010-09-30
2010-08-27 6794.98 未披露 定期报告 2010-08-24
2010-08-27 6793.10 未披露
更多>>
Stock options exercised Issuance of common stock in a public offering, net of financing costs
2010-06-30
2010-04-30 5746.15 未披露 定期报告 2010-04-26
2010-04-30 5741.40 未披露 定期报告 2010-03-31
2009-08-28 5705.76 未披露 定期报告 2009-08-25
2009-08-28 5694.70 未披露
更多>>
From June 30, 2008 to June 30, 2009 Stock options exercised Restricted stock issued Issuance of Common Stock in a private offering, net of financing costs
2009-06-30
2008-09-02 5078.58 未披露 定期报告 2008-08-28
2008-09-02 5077.80 未披露
更多>>
From June 30, 2007 to June 30, 2008 Stock options exercised Issuance of Common Stock in a private offering, net of financing costs
2008-06-30
2007-08-30 4244.94 未披露 定期报告 2007-08-24
2007-08-30 4234.60 未披露
更多>>
From June 30, 2006 to June 30, 2007 Stock options exercised
2007-06-30
2006-08-28 4148.50 未披露 定期报告 2006-08-23
2006-08-28 4147.40 未披露
更多>>
From June 30, 2005 to June 30, 2006 Stock options exercised
2006-06-30
2005-08-29 4107.40 未披露 定期报告 2005-08-23
2005-08-29 4102.00 未披露
更多>>
From June 30, 2004 to June 30, 2005 Stock options exercised Issuance of stock for directors’compensation
2005-06-30
2004-08-20 4078.94 未披露 定期报告 2004-08-18
2004-08-20 4078.72 未披露
更多>>
From June 30, 2003 to June 30, 2004 Stock options exercised Issuance of stock and stock units for directors' compensation
2004-06-30
2003-09-26 4058.63 未披露
更多>>
From June 30, 2002 to June 30, 2003 Stock options exercised Warrants exercised Issuance of stock and stock units for directors' compensation Repurchases of common stock
2003-06-30
2003-09-26 4220.19 未披露 定期报告 2002-12-31
2002-09-20 4387.85 未披露 定期报告 2002-09-13
2002-09-20 4015.56 未披露
更多>>
From June 30, 2001 to June 30, 2002 Stock options exercised Warrants exercised, net of financing costs Issuance of restricted shares of common stock in settlement of a claim Issuance of stock and stock units for director's compensation
2002-06-30
2001-09-28 3855.29 未披露 定期报告 2001-07-31
2001-09-28 3853.54 未披露
更多>>
From June 30, 2000 to June 30, 2001 Stock options exercised Exercise of put option Warrants exercised Issuance of common stock to public,net of financing costs Issuance of common stock to Abgenix, Inc
2001-06-30
2000-09-27 3409.14 未披露 定期报告 2000-09-18
2000-09-27 3305.07 未披露
更多>>
From June 30, 1999 to June 30, 2000 Stock options exercised Exercise of put option Warrants exercised Conversion of Series E Convertible Preferred Stock into Common Stock
2000-06-30
1999-09-29 2669.23 未披露 定期报告 1999-09-15
1999-09-29 2566.88 0.24
更多>>
From June 30, 1998 to June 30, 1999 Issuance of Series E Convertible Preferred Stock, net of financing costs Issuance of Common Stock in exchange for Series E Preferred Stock placement services
1999-06-30
1998-09-29 2541.96 0.12
更多>>
From June 30, 1997 to June 30, 1998 Stock options exercised Issuance of common stock Conversion of Series A convertible preferred stock into common stock Conversion of Series D convertible preferred stock into common stock Conversion of Series C convertible preferred stock into common stock Issuance of Series E Convertible Preferred Stock, net of financing costs
1998-06-30
1997-09-26 2297.99 未披露 定期报告 1997-09-12
1997-09-26 2177.98 0.28
更多>>
From June 30, 1996 to June 30, 1997 Stock options exercised Issuance of common stock Conversion of convertible debentures into common stock Exchange of convertible debentures for series A convertible preferred stock Issuance of Series B convertible preferred stock Issuance of Series C convertible preferred stock Issuance of Series D convertible preferred stock Conversion of Series A convertible preferred stock into common stock Conversion of Series B convertible preferred stock into common stock Conversion of Series C convertible preferred stock into common stock
1997-06-30
1996-09-12 1695.98 未披露 定期报告 1996-09-09
1996-09-12 1659.99 未披露
更多>>
From June 30, 1995 to June 30, 1996 Stock options excercised Conversion of convertible debentures
1996-06-30
1995-09-28 1258.66 未披露 定期报告 1995-09-18
1995-09-28 1257.86 未披露
更多>>
From June 30, 1994 to June 30, 1995 Stock options excercised
1995-06-30
From June 30, 2023 to September 30, 2023 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Directors’ deferred share unit and common stock compensation Issuance of common stock pursuant to pre-funded warrant exchange
From March 31, 2023 to June 30, 2023 Issuance of common stock pursuant to pre-funded warrant exchange Issuance of Series A Preferred Stock in exchange for common stock Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Issuance of common stock, net of issuance costs Directors’ deferred share unit and common stock compensation
Common stock offered 26,000,000 shares by the company Pursuant to the terms of the Underwriting Agreement, the Company granted the Underwriters an option, exercisable for 30 days following the date of the Underwriting Agreement, to purchase up to an additional 3,900,000 shares of Common Stock at the same price, which the Underwriters exercised on May 5, 2023. The Offering is scheduled to close on May 9, 2023, subject to the satisfaction of customary closing conditions.
From December 31, 2022 to March 31, 2023 Directors’ deferred share unit and common stock compensation Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan
From December 31, 2021 to December 31, 2022 Issuance of common stock, net of issuance costs Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Restricted stock units vested
From June 30, 2022 to September 30, 2022 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan
From March 31, 2022 to June 30, 2022 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan
From December 31, 2021 to March 31, 2022 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Restricted stock units vested
From December 31, 2020 to December 31, 2021 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Issuance of common stock, net of issuance costs Conversion of convertible senior notes Restricted stock units vested Restricted stock award forfeitures
1.Common stock offered by company 11,636,364 shares.the Company granted the Underwriters an option, exercisable for 30 days following the date of the Underwriting Agreement, to purchase up to an additional 5,850,000 shares of Common Stock at the same price. 2.The number of shares of common stock to be outstanding after this offering is based on 202,443,297 shares of common stock outstanding as of September 30, 2021.
From June 30, 2021 to September 30, 2021 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Issuance of common stock, net of issuance costs Restricted stock award forfeitures
From March 31, 2021 to June 30, 2021 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Conversion of convertible senior notes
From December 31, 2020 To March 31, 2021 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Issuance of common stock, net of issuance costs Restricted stock units vested
From December 31, 2019 to December 31, 2020 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Issuance of common stock, net of issuance costs Restricted stock units vested Restricted stock award forfeitures
From June 30, 2020 to September 30, 2020 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan
From March 31, 2020 to June 30, 2020 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Restricted stock units vested
From December 31, 2019 to March 31, 2020 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Issuance of common stock, net of issuance costs Restricted stock units vested Restricted stock award forfeitures
from December 31, 2018 to December 31, 2019 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Restricted stock award - net of forfeitures
from June 30, 2019 to September 30, 2019 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Restricted stock award
from March 31, 2019 to June 30, 2019 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Restricted stock award
from December 31, 2018 to March 31, 2019 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan
from December 31, 2017 to December 31, 2018 Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan Issuance of common stock Directors' deferred share units converted
from December 31, 2017 to September 30, 2018 Stock options exercised Issuance of common stock Directors' deferred share units converted
from December 31, 2016 to December 31, 2017 Stock options exercised Issuance of common stock Restricted stock award - net of forfeitures Conversion of debt Directors' deferred share units converted
from June 30, 2016 to December 31, 2016 Restricted stock award - net of forfeitures
from June 30, 2015 to June 30, 2016 Stock options exercised Restricted stock award
from June 30, 2014 to June 30, 2015 Stock options exercised Restricted stock award
from June 30, 2013 to June 30, 2014 Stock options exercised Directors' deferred share units converted
from June 30, 2012 to June 30, 2013 Stock options exercised Restricted stock award Issuance of common stock in a public offering, net of issuance costs
from June 30, 2011 to June 30, 2012 Stock options exercised Directors' deferred share units converted
from June 30, 2010 to June 30, 2011 Stock options exercised Issuance of common stock in a public offering, net of issuance costs
Stock options exercised Issuance of common stock in a public offering, net of financing costs
From June 30, 2008 to June 30, 2009 Stock options exercised Restricted stock issued Issuance of Common Stock in a private offering, net of financing costs
From June 30, 2007 to June 30, 2008 Stock options exercised Issuance of Common Stock in a private offering, net of financing costs
From June 30, 2006 to June 30, 2007 Stock options exercised
From June 30, 2005 to June 30, 2006 Stock options exercised
From June 30, 2004 to June 30, 2005 Stock options exercised Issuance of stock for directors’compensation
From June 30, 2003 to June 30, 2004 Stock options exercised Issuance of stock and stock units for directors' compensation
From June 30, 2002 to June 30, 2003 Stock options exercised Warrants exercised Issuance of stock and stock units for directors' compensation Repurchases of common stock
From June 30, 2001 to June 30, 2002 Stock options exercised Warrants exercised, net of financing costs Issuance of restricted shares of common stock in settlement of a claim Issuance of stock and stock units for director's compensation
From June 30, 2000 to June 30, 2001 Stock options exercised Exercise of put option Warrants exercised Issuance of common stock to public,net of financing costs Issuance of common stock to Abgenix, Inc
From June 30, 1999 to June 30, 2000 Stock options exercised Exercise of put option Warrants exercised Conversion of Series E Convertible Preferred Stock into Common Stock
From June 30, 1998 to June 30, 1999 Issuance of Series E Convertible Preferred Stock, net of financing costs Issuance of Common Stock in exchange for Series E Preferred Stock placement services
From June 30, 1997 to June 30, 1998 Stock options exercised Issuance of common stock Conversion of Series A convertible preferred stock into common stock Conversion of Series D convertible preferred stock into common stock Conversion of Series C convertible preferred stock into common stock Issuance of Series E Convertible Preferred Stock, net of financing costs
From June 30, 1996 to June 30, 1997 Stock options exercised Issuance of common stock Conversion of convertible debentures into common stock Exchange of convertible debentures for series A convertible preferred stock Issuance of Series B convertible preferred stock Issuance of Series C convertible preferred stock Issuance of Series D convertible preferred stock Conversion of Series A convertible preferred stock into common stock Conversion of Series B convertible preferred stock into common stock Conversion of Series C convertible preferred stock into common stock
From June 30, 1995 to June 30, 1996 Stock options excercised Conversion of convertible debentures
From June 30, 1994 to June 30, 1995 Stock options excercised
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。

【免责声明】本产品中的行情数据及资讯信息来源于第三方，长江证券不对收集数据的版权、真实性、准确性及传输过程中发生的传送错误承担法律责任。本内容仅供参考，不作为投资决策依据，长江证券不对因据此操作产生的盈亏承担任何责任。投资有风险，入市需谨慎。